إعلان
إعلان

CRVO

CRVO logo

CervoMed Inc. Common Stock

7.79
USD
برعاية
-0.17
-2.08%
٠٨ يناير, ١٥:٥٤ UTC -5
مغلق
exchange

بعد الإغلاق

7.79

0.00
0.00%

تقارير أرباح CRVO

النسبة الإيجابية المفاجئة

CRVO تفوق 14 من 29 آخر التقديرات.

48%

التقرير التالي

بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$986.00K
/
-$0.63
التغير الضمني من Q3 25 (Revenue/ EPS)
+205.67%
/
-25.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-54.39%
/
-21.25%

CervoMed Inc. Common Stock earnings per share and revenue

On ٠٧ نوفمبر ٢٠٢٥, CRVO reported earnings of -0.84 USD per share (EPS) for Q3 25, missing the estimate of -0.78 USD, resulting in a -6.68% surprise. Revenue reached 322.57 ألف, compared to an expected 1.45 مليون, with a -77.68% difference. The market reacted with a -0.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of -0.63 USD, with revenue projected to reach 986.00 ألف USD, implying an نقصان of -25.00% EPS, and زيادة of 205.67% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, CervoMed Inc. Common Stock reported EPS of -$0.84, missing estimates by -6.68%, and revenue of $322.57K, -77.68% below expectations.
The stock price moved down -0.29%, changed from $6.92 before the earnings release to $6.90 the day after.
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
Based on 9 المحللين, CervoMed Inc. Common Stock is expected to report EPS of -$0.63 and revenue of $986.00K for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان